Fig. 7From: Topical gel based nanoparticles for the controlled release of oleanolic acid: design and in vivo characterization of a cubic liquid crystalline anti-inflammatory drug- In vitro drug release profiles of OA-loaded LCNP up to 12 hBack to article page